Prof Anton Berns speaks to ecancer about what preclinical models for SCLC will provide us for the future mouse models.

Prof Berns describes a recent review that he worked on about what mouse models can teach us about lung cancer, particularly about different subsets of lung cancer such as small-cell lung cancer.

He explains that researchers know very little about the early phases of lung cancer, and discusses the benefits and restrictions using mouse models.

This programme has been supported by an unrestricted educational grant from Bristol Myers Squibb.